Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Regina-Veronicka Kalaydina, Komal Bajwa, Bessi Qorri, Alexandria Decarlo & Myron R Szewczuk. (2018) Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International Journal of Nanomedicine 13, pages 4727-4745.
Read now
Read now
Carine C Drewes, Luana A Fiel, Celina G Bexiga, Ana Carolina C Asbahr, Mayara K Uchiyama, Bruno Cogliati, Koiti Araki, Sílvia S Guterres, Adriana R Pohlmann & Sandra P Farsky. (2016) Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models. International Journal of Nanomedicine 11, pages 1261-1279.
Read now
Read now
Vanna Sanna, Nicolino Pala & Mario Sechi. (2014) Targeted therapy using nanotechnology: focus on cancer. International Journal of Nanomedicine 9, pages 467-483.
Read now
Read now
Yan Shi, Rui Qin, Zhi-Kuan Wang & Guang-Hai Dai. (2013) Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma. OncoTargets and Therapy 6, pages 585-591.
Read now
Read now
Jiezhong Chen, Renfu Shao, Xu Dong Zhang & Chen Chen. (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8, pages 2677-2688.
Read now
Read now
Articles from other publishers (51)
Zhengxing Su, Jinlong Zhao, Xi Zhao, Jia Xie, Ming Li & Dong Zhao. (2023) Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products. International Journal of Pharmaceutics 635, pages 122711.
Crossref
Crossref
Gabriela Bordeianu, Nina Filip, Andrei Cernomaz, Bogdan Veliceasa, Loredana Liliana Hurjui, Alin Constantin Pinzariu, Mihaela Pertea, Andreea Clim, Mihai Vasile Marinca & Ionela Lacramioara Serban. (2023) The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer. Biomedicines 11:3, pages 705.
Crossref
Crossref
Faisal ALMuhizi, Leticia De Las Vecillas Sanchez, Lucy Gilbert, Ana M. Copaescu & Ghislaine A. C. Isabwe. (2022) Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review. Clinical Reviews in Allergy & Immunology 62:3, pages 534-547.
Crossref
Crossref
Rajib Hossain, Rasel Ahmed Khan, Muhammad Torequl Islam, Divya Jain, Pracheta Janmeda, Obinna Chukwuemeka Godfrey, Shiwali Bisht & Aakanksha Bharati. (2021) Doxorubicin hydrochloride liposome and albumin-bound paclitaxel in cancer: a nanotechnology perspective. The Applied Biology & Chemistry Journal, pages 59-65.
Crossref
Crossref
Oluyomi Stephen Adeyemi, Chiagoziem Anariochi Otuechere, Adewale Adewuyi, Oluwakemi Josephine Awakan & David Adeiza Otohinoyi. 2021. Nanopharmaceuticals: Principles and Applications Vol. 2. Nanopharmaceuticals: Principles and Applications Vol. 2
265
288
.
Wheemoon Cho, Min Sup Kim, Kee-Ho Lee, Sang Jun Park, Hyun-Jin Shin, Yong Jin Lee, Sang Bum Kim, Youngsook Son & Chun-Ho Kim. (2020) Ionizing radiation attracts tumor targeting and apoptosis by radiotropic lysyl oxidase traceable nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102141.
Crossref
Crossref
Eric L. Yarnell. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
879
882.e1
.
Tala M. Abu Samaan, Marek Samec, Alena Liskova, Peter Kubatka & Dietrich Büsselberg. (2019) Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 9:12, pages 789.
Crossref
Crossref
Feng Li, Hebao Yuan, Huixia Zhang, Miao He, Jinhui Liao, Nianhang Chen, Yan Li, Simon Zhou, Maria Palmisano, Alex Yu, Manjunath Pai & Duxin Sun. (2019)
Neonatal Fc Receptor (FcRn) Enhances Tissue Distribution and Prevents Excretion of
nab-
Paclitaxel
. Molecular Pharmaceutics 16:6, pages 2385-2393.
Crossref
Crossref
Moses Bio, Kazi Md Mahabubur Rahman, Irene Lim, Pallavi Rajaputra, Robert E. Hurst & Youngjae You. (2019) Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy. Bioorganic & Medicinal Chemistry Letters 29:12, pages 1537-1540.
Crossref
Crossref
Xiaodong Xie, Yingying Zhang, Fengqiao Li, Tingting Lv, Ziying Li, Haijun Chen, Lee Jia & Yu Gao. (2019) Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery. Current Cancer Drug Targets 19:4, pages 257-276.
Crossref
Crossref
Denise Damasceno Guerreiro, Laritza Ferreira de Lima, Naiza Arcângela Ribeiro de Sá, Gildas Mbemya Tetaping, Benner Geraldo Alves, Carlos Henrique Lobo, Otília Deusdênia Loiola, Johan Smitz, José Ricardo de Figueiredo & Ana Paula Ribeiro Rodrigues. (2019) In vitro study of Withanolide D toxicity on goat preantral follicles and its effects on the cell cycle. Reproductive Toxicology 84, pages 18-25.
Crossref
Crossref
Md Sazzad Hassan, Niranjan Awasthi, Jun Li, Fiona Williams, Margaret A. Schwarz, Roderich E. Schwarz & Urs von Holzen. (2018) Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma. Translational Oncology 11:2, pages 426-435.
Crossref
Crossref
Ana L. Silva, Liane I.F. Moura, Bárbara Carreira, João Conniot, Ana I. Matos, Carina Peres, Vanessa Sainz, Liana C. Silva, Rogério S. Gaspar & Helena F. Florindo. 2018. Biomedical Applications of Functionalized Nanomaterials. Biomedical Applications of Functionalized Nanomaterials
399
448
.
In Rae Cho, Huapyong Kang, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jae Bock Chung, Chansik An, Mi-Suk Park, So Young Jung & Seungmin Bang. (2017) Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study. Seminars in Oncology 44:6, pages 420-427.
Crossref
Crossref
Yangyang Gao, Junying Chen, Xiqian Zhang, Huiru Xie, Yanran Wang & Shuquan Guo. (2017) Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study. Journal of Chromatographic Science 55:3, pages 222-231.
Crossref
Crossref
Z. Kejík, R. Kaplánek, T. Bříza, M. Havlík, J. Králová, P. Martásek & V. Král. 2017. Comprehensive Supramolecular Chemistry II. Comprehensive Supramolecular Chemistry II
421
440
.
Deep Pooja, Hitesh Kulhari, Madhusudana Kuncha, Shyam S. Rachamalla, David J. Adams, Vipul Bansal & Ramakrishna Sistla. (2016) Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles. Molecular Pharmaceutics 13:11, pages 3903-3912.
Crossref
Crossref
Emika Ichioka, Akiko Iguchi-Manaka, Takehiro Oikawa, Aya Sawa, Mai Okazaki, Takeshi Saito, Hiroko Kiyomatsu, Tatsuhiko Ikeda, Hiroko Bando & Hisato Hara. (2016) A case of hemorrhagic cystitis caused by nab-paclitaxel. International Cancer Conference Journal 5:4, pages 187-191.
Crossref
Crossref
N V Rajeshkumar, Shinichi Yabuuchi, Shweta G Pai, Zeen Tong, Shihe Hou, Scott Bateman, Daniel W Pierce, Carla Heise, Daniel D Von Hoff, Anirban Maitra & Manuel Hidalgo. (2016) Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. British Journal of Cancer 115:4, pages 442-453.
Crossref
Crossref
Carlos Pérez-Medina, Dalya Abdel-Atti, Jun Tang, Yiming Zhao, Zahi A. Fayad, Jason S. Lewis, Willem J. M. Mulder & Thomas Reiner. (2016) Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nature Communications 7:1.
Crossref
Crossref
Imtiaz A. Siddiqui & Vanna Sanna. (2016) Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Molecular Nutrition & Food Research 60:6, pages 1330-1341.
Crossref
Crossref
Guanying Chen, Indrajit Roy, Chunhui Yang & Paras N. Prasad. (2016) Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy. Chemical Reviews 116:5, pages 2826-2885.
Crossref
Crossref
Xinzhe Yu & Chen Jin. (2015) Application of albumin-based nanoparticles in the management of cancer. Journal of Materials Science: Materials in Medicine 27:1.
Crossref
Crossref
Yuan Yuan, Yan Zhang, Lin Shi, Jing-Feng Mei, Jif-Eng Feng & Bo Shen. (2015) Clinical Research on Albumin-Bound Paclitaxel-Based Chemotherapy for Advanced Esophageal Cancer. Asian Pacific Journal of Cancer Prevention 16:12, pages 4993-4996.
Crossref
Crossref
Jeffrey A Keelan, Joan W Leong, Diwei Ho & K Swaminatha Iyer. (2015) Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy. Nanomedicine 10:14, pages 2229-2247.
Crossref
Crossref
Donna V. Peralta, Zahra Heidari, Srikanta Dash & Matthew A. Tarr. (2015) Hybrid Paclitaxel and Gold Nanorod-Loaded Human Serum Albumin Nanoparticles for Simultaneous Chemotherapeutic and Photothermal Therapy on 4T1 Breast Cancer Cells. ACS Applied Materials & Interfaces 7:13, pages 7101-7111.
Crossref
Crossref
Abdolrasoul SoleimaniMahmoud M. Abd Rabo MoustafaAneta BoreckiElizabeth R. Gillies. (2015) A comparison of covalent and noncovalent strategies for paclitaxel release using poly(ester amide) graft copolymer micelles. Canadian Journal of Chemistry 93:4, pages 399-405.
Crossref
Crossref
Zehua Bian, Yang Yu, Chao Quan, Rongwei Guan, Yan Jin, Jie� Wu, Lidan Xu, Feng Chen, Jing Bai, Wenjing Sun & Songbin Fu. (2014) RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments. Molecular Medicine Reports.
Crossref
Crossref
Anke Hahnenkamp, Wael Alsibai, Christoph Bremer & Carsten Höltke. (2014) Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag. Journal of Controlled Release 186, pages 32-40.
Crossref
Crossref
Nuno A. Fonseca, Ana C. Gregório, Ângela Valério-Fernandes, Sérgio Simões & João N. Moreira. (2014) Bridging cancer biology and the patients' needs with nanotechnology-based approaches. Cancer Treatment Reviews 40:5, pages 626-635.
Crossref
Crossref
V Krishnan & A K Rajasekaran. (2013) Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy. Clinical Pharmacology & Therapeutics 95:2, pages 168-178.
Crossref
Crossref
Yuzhou Wu, Chuang Li, Felix Boldt, Yanran Wang, Seah Ling Kuan, Thuy Tam Tran, Viktoria Mikhalevich, Christina F?rtsch, Holger Barth, Zhongqiang Yang, Dongsheng Liu & Tanja Weil. (2014) Programmable protein?DNA hybrid hydrogels for the immobilization and release of functional proteins. Chem. Commun. 50:93, pages 14620-14622.
Crossref
Crossref
Eddy Pasquier, Maria Kavallaris & Nicolas Andre. 2014. Metronomic Chemotherapy. Metronomic Chemotherapy
69
90
.
Jaydev R. Upponi & Vladimir P. Torchilin. 2014. Nano-Oncologicals. Nano-Oncologicals
3
45
.
Yuzhou Wu, Susann Ihme, Michaela Feuring‐Buske, Seah Ling Kuan, Klaus Eisele, Markus Lamla, Yanran Wang, Christian Buske & Tanja Weil. (2012) A Core–Shell Albumin Copolymer Nanotransporter for High Capacity Loading and Two‐Step Release of Doxorubicin with Enhanced Anti‐Leukemia Activity. Advanced Healthcare Materials 2:6, pages 884-894.
Crossref
Crossref
Apostolia M. Tsimberidou, Yang Ye, Jennifer Wheler, Aung Naing, David Hong, Uchechi Nwosu, Kenneth R. Hess & Robert A. Wolff. (2013) A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases. Cancer Chemotherapy and Pharmacology 71:4, pages 955-963.
Crossref
Crossref
G. von Minckwitz, M. Martin, G. Wilson, E. Alba, M. Schmidt, L. Biganzoli & A. Awada. (2013) Optimizing taxane use in MBC in the emerging era of targeted chemotherapy. Critical Reviews in Oncology/Hematology 85:3, pages 315-331.
Crossref
Crossref
Seth M Miller & Andrew Z Wang. (2013) Nanomedicine in chemoradiation. Therapeutic Delivery 4:2, pages 239-250.
Crossref
Crossref
Michael T. Murray & Cathryn M. Flanagan. 2013. Textbook of Natural Medicine. Textbook of Natural Medicine
1059
1062
.
Yuzhou Wu, Er Kai Shih, Arvind Ramanathan, Subhash Vasudevan & Tanja Weil. (2012) Nano-Sized Albumin-Copolymer Micelles for Efficient Doxorubicin Delivery. Biointerphases 7:1.
Crossref
Crossref
Aparna Dagar, Antonina Kuzmis, Israel Rubinstein, Marin Sekosan & Hayat Onyuksel. (2012) VIP-targeted cytotoxic nanomedicine for breast cancer. Drug Delivery and Translational Research 2:6, pages 454-462.
Crossref
Crossref
Fabrizio Marcucci & Angelo Corti. (2012) Improving drug penetration to curb tumor drug resistance. Drug Discovery Today 17:19-20, pages 1139-1146.
Crossref
Crossref
Yung Choi. (2012) Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncology Reports.
Crossref
Crossref
Virginia Zabaleta, Gilles Ponchel, Hesham Salman, Maite Agüeros, Christine Vauthier & Juan M. Irache. (2012) Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. European Journal of Pharmaceutics and Biopharmaceutics 81:3, pages 514-523.
Crossref
Crossref
Pengxiang Zhao & Didier Astruc. (2012) Docetaxel Nanotechnology in Anticancer Therapy. ChemMedChem 7:6, pages 952-972.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:3, pages 345-354.
Crossref
Crossref
Patricia Calleja, Judit Huarte, Maite Agüeros, Luisa Ruiz-Gatón, Socorro Espuelas & Juan M Irache. (2012) Molecular buckets: cyclodextrins for oral cancer therapy. Therapeutic Delivery 3:1, pages 43-57.
Crossref
Crossref
Yasar Akdogan, Yuzhou Wu, Klaus Eisele, Manuela Schaz, Tanja Weil & Dariush Hinderberger. (2012) Host–guest interactions in polycationic human serum albumin bioconjugates. Soft Matter 8:43, pages 11106.
Crossref
Crossref
Nazila Kamaly, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic-Moreno & Omid C. Farokhzad. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews 41:7, pages 2971.
Crossref
Crossref
Xiang Fei, Wenting Xu, Yuan Yue & Mi-Kyung Lee. (2011) Preparation and Characterization of Tributyrin Sub-micron Emulsion as Carrier for Paclitaxel. Journal of Pharmaceutical Investigation 41:5, pages 295-300.
Crossref
Crossref